Targeted Therapies: Could anyone provide - or... - CLL Support

CLL Support

22,868 members39,237 posts

Targeted Therapies

Lil0ppie profile image
6 Replies

Could anyone provide - or point me in the direction of - an explanation for how targeted therapies are able to distinguish between cancerous and non-cancerous cells? This seems like a fundamental benefit of the new treatments.

Thanks.

Written by
Lil0ppie profile image
Lil0ppie
To view profiles and participate in discussions please or .
6 Replies
AussieNeil profile image
AussieNeilPartnerAdministrator

It's not that targeted therapies can distinguish between cancerous and non-cancerous cells - at least so far. The advantage they have over older "chemo" treatments, is that they strongly target maturing B cells, leaving other body cells and mature B cells largely untouched. They do this by targeting proteins highly specific to B cells which can also be over expressed.

The older "chemo" treatments target cells undergoing fast cell division, such as along our digestive system, where they need to be frequently replaced through daily wear and tear. Hence the greater impact on bone marrow production and the occurrence of mouth ulcers and distressing GI issues which is more common with the older treatments.

Neil

Lil0ppie profile image
Lil0ppie in reply to AussieNeil

Thanks. Does this mean that over time you’ll have fewer mature B cells?

AussieNeil profile image
AussieNeilPartnerAdministrator in reply to Lil0ppie

Yes, that's why it's common to see a drop in antibodies/immunoglobulins, as they are produced by mature B cells/plasma cells.Eventually healthy B cell production recommences after treatment, but it can take a while, up to a year after the last rituximab or obinutuzumab infusion. These monoclonal antibody treatments selectively target the CD20 protein cluster of differentiation almost exclusively found on maturing B cells.

Neil

Lil0ppie profile image
Lil0ppie

Thanks. This is really informative. Presumably it will be a more long term issue for those of us on BTKi’s?

AussieNeil profile image
AussieNeilPartnerAdministrator in reply to Lil0ppie

As you have appreciated, with maintenance therapies, healthy B cell counts are also suppressed, though because they tend to have a lower expression of BTKi (or BCL-2) than CLL cells, sometimes people on maintenance therapy do somewhat respond to vaccinations.

Neil

Lil0ppie profile image
Lil0ppie

Thanks again!

Not what you're looking for?

You may also like...

VACCINATIONS FOR PEOPLE WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL/SLL)

This pinned post replaces our earlier reference post about vaccinations for those with CLL/SLL. It...

Specialsts

Just a question really, has it happened to anyone! Got my diagnosis a year and half ago CLL, never...

YABTKi or Yet Another BTK inhibitor - the A to Z list of Bruton's Tyrosine Kinase Inhibitors for CLL following Ibrutinib's success

I'll admit that YABTKi is not a recognised CLL related acronym, (acronym lists are here...

CT scan Boney lesions, I have just had a CT scan and boney lesions have been detected on my pelvis and lower spine, is this CLL related.

diagnosed 9 years ago, my platelets have started to drop from 240 to 144 in the last 6 months or...

Acalabrutinib, NYU, Columbia Presbyterian, and Dr. Nicole Lamanna

Good evening, Soon, I will start taking alacabrutinib (also known as Calquence), and NYU is...